5,848
Views
15
CrossRef citations to date
0
Altmetric
Oncology

Total cost of testing for genomic alterations associated with next-generation sequencing versus polymerase chain reaction testing strategies among patients with metastatic non-small cell lung cancer

ORCID Icon, ORCID Icon, ORCID Icon, , , & show all
Pages 457-468 | Received 10 Feb 2022, Accepted 11 Mar 2022, Published online: 30 Mar 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.